Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

B. A. Silk, D.; M. Davis, Andrew; Vulevic, Jelena; Tzortzis, George; R. Gibson, Glenn

doi:10.1111/j.1365-2036.2008.03911.x

Public

Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

Published in Alimentary Pharmacology & Therapeutics • Dec 2, 2008

Authors:

D. B. A. Silk

Andrew M. Davis

Jelena Vulevic

Abstract

BACKGROUND: Gut microflora-mucosal interactions may be involved in the pathogenesis of irritable bowel syndrome (IBS). AIM: To investigate the efficacy of a novel prebiotic trans-galactooligosaccharide in changing the colonic microflora and improve the symptoms in IBS sufferers. METHODS: In all, 44 ...

Subject

Prebiotic

Irritable bowel syndrome

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!